Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities.
about
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approachMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesTraumatic injuries in patients with diabetes mellitusHypoglycemia in Patients with Diabetes and Renal DiseaseAvoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesDiabetic kidney disease: a report from an ADA Consensus ConferenceGlucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilizedEffect of Structured Physical Activity on Respiratory Outcomes in Sedentary Elderly Adults with Mobility LimitationsFear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.Diabetes in older adultsNeurocognitive changes and their neural correlates in patients with type 2 diabetes mellitusOptimal therapy of type 2 diabetes: a controversial challengeThe effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitusHypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes.KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.Exercise Metabolism in Nonobese Patients with Type 2 Diabetes Following the Acute Restoration of NormoglycaemiaManaging preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional studyHypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registryNational trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.Diabetes in older adults: a consensus reportLower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study.Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE)Exercise-related hypoglycemia in diabetes mellitusA 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs.Age-related metabolic fatigue during low glucose conditions in rat hippocampus.A cross-sectional study of glucose regulation in young adults with very low birth weight: impact of male gender on hyperglycaemiaA novel nasal powder formulation of glucagon: toxicology studies in animal modelsUpdate on strategies limiting iatrogenic hypoglycemia.Technology to Reduce Hypoglycemia.Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression.Prevalence, Clinical Correlates, and Use of Glucose-Lowering Drugs among Older Patients with Type 2 Diabetes Living in Long-Term Care Facilities.Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes.Survey of Hypoglycemia in Elderly People With Type 2 Diabetes Mellitus in Japan.Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring StudyPatients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practiceCase-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke
P2860
Q24635648-A0308E1D-82ED-4C90-840B-BA7DDC787E38Q24642503-0B06F85D-96A5-4017-BA79-AC363F6A265FQ26751033-4B15B845-EDED-4543-B825-F64E9DE10A05Q26799515-EF9E5136-F63D-4CA2-B6C0-DE2BD8192855Q26827955-1D2E0301-7C3C-462A-9A14-987E8C46FDD4Q27012546-DE42F9F9-9999-4DDF-9E20-E45F2E65FBF2Q28268406-F47C46C4-BE6C-4FEC-A3F8-43AA2E11483EQ28390472-3507FB68-9357-4CA3-AB1E-38A5C8935C47Q30438098-1F688D5C-4C75-48C7-8F58-9CB08D40326CQ30528669-2093A119-2A2F-474A-9577-71EE76816B7DQ30836865-6C27EE80-16FD-4CE0-A724-A160360D0677Q33577712-EC4C1913-60C5-48E0-92AF-FFD99189FA0FQ33579759-B21F92D4-3F46-4E81-AE38-CCED13E74616Q33699361-D8093D9B-DD6F-4694-AE1B-244CB8FA2616Q33739048-96F7CFC8-0BC6-4B55-97FD-E79F15796D3BQ33771570-43E80AF4-85D0-490C-89CA-9CF799081FF2Q33787062-B33655C7-A191-4D5B-9369-318ED40F1499Q34095380-BBAAFBBB-A1BE-454E-B226-F4BC26B24D18Q34114735-BFF5057A-3BBF-4A1C-A58A-26BB5BB5E50AQ34116963-8735B95E-5317-4FB1-AE8A-996C52D13EB6Q34122776-23EDA9CB-6EAB-4674-B94A-3448750AADFDQ34308751-E4E9453E-AD7C-45F3-92C0-BAFEA4D7AEDCQ34468769-967E715D-2627-456A-9530-64560F458A7DQ34570561-F10858B1-7C80-46E5-8774-2208A25493D4Q34576063-433AB447-5885-4463-BE29-8F5013BC1EFCQ35336944-9DB783C3-51D3-4C46-B599-BB79C4E88CE1Q35642307-3869D866-3245-466D-A118-497A9505BF44Q35646715-2B1282DE-8152-46F7-9651-C6704D3556CDQ35743023-850B1392-5FF1-4987-A320-191385D6BF2DQ35821667-31FD7389-4890-4CF5-B4D9-B4B00090966AQ35881959-B92E9901-18B4-43B5-8E0F-1E888EF4B6C6Q35918438-E0075999-7E22-4AEB-A864-C20F21A7DDFCQ35997284-1E251228-6073-4181-9279-DE0F3CB068A5Q36016012-73579BB2-51FF-438B-A0A7-DB673CADD40DQ36074711-4236C286-EF3C-473C-9174-17AA3DE65C7BQ36098838-36045173-73FD-4A29-B81A-0DAE5E58AAB8Q36223763-EBA121C7-5089-4BF4-B800-487E0215B40AQ36340505-65C4B4B1-EEA0-4969-A5DE-A16175E0D5D7Q36432159-C1AAA841-DBAB-4998-9D00-C2715B781C6AQ36520595-CD79317C-D1AA-415A-B22F-DE8FEBA86B5A
P2860
Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@ast
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@en
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@nl
type
label
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@ast
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@en
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@nl
prefLabel
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@ast
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@en
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@nl
P921
P1433
P1476
Hypoglycemia in type 2 diabete ...... ifferent treatment modalities.
@en
P2093
Brian M Frier
Nicola N Zammitt
P304
P356
10.2337/DIACARE.28.12.2948
P407
P577
2005-12-01T00:00:00Z